- Home
- EYEN vs HSCS Comparison
EYEN vs HSCS Comparison
Compare EYEN & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EYEN
- HSCS
- Stock Information
- Founded
- EYEN 2014
- HSCS 2007
- Country
- EYEN United States
- HSCS United States
- Employees
- EYEN N/A
- HSCS N/A
- Industry
- EYEN Biotechnology: Pharmaceutical Preparations
- HSCS Medical Specialities
- Sector
- EYEN Health Care
- HSCS Health Care
- Exchange
- EYEN Nasdaq
- HSCS Nasdaq
- Market Cap
- EYEN 4.0M
- HSCS 3.8M
- IPO Year
- EYEN 2018
- HSCS 2022
- Fundamental
- Price
- EYEN $1.68
- HSCS $3.69
- Analyst Decision
- EYEN Hold
- HSCS Strong Buy
- Analyst Count
- EYEN 4
- HSCS 2
- Target Price
- EYEN $2.00
- HSCS $13.50
- AVG Volume (30 Days)
- EYEN 267.4K
- HSCS 19.2K
- Earning Date
- EYEN 03-17-2025
- HSCS 03-13-2025
- Dividend Yield
- EYEN N/A
- HSCS N/A
- EPS Growth
- EYEN N/A
- HSCS N/A
- EPS
- EYEN N/A
- HSCS N/A
- Revenue
- EYEN $31,832.00
- HSCS $14,700.00
- Revenue This Year
- EYEN $23,413.60
- HSCS $174.19
- Revenue Next Year
- EYEN $400.98
- HSCS $4,100.00
- P/E Ratio
- EYEN N/A
- HSCS N/A
- Revenue Growth
- EYEN 2557.10
- HSCS 151.28
- 52 Week Low
- EYEN $1.67
- HSCS $2.36
- 52 Week High
- EYEN $205.60
- HSCS $18.50
- Technical
- Relative Strength Index (RSI)
- EYEN 27.62
- HSCS 51.97
- Support Level
- EYEN $1.67
- HSCS $3.70
- Resistance Level
- EYEN $1.94
- HSCS $4.10
- Average True Range (ATR)
- EYEN 0.26
- HSCS 0.30
- MACD
- EYEN 0.22
- HSCS 0.03
- Stochastic Oscillator
- EYEN 0.80
- HSCS 59.00
About EYEN Eyenovia Inc.
Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.